However, he cautions the likelihood any single vaccine will work is "One in ten. So a 90 percent drop attrition rate. That means that you probably have to have at least twenty vaccines moving into clinical trials in order to get a couple that you think might be effective. Hotez and his team are working towards the development of a vaccine. He's pushing for a balance of new and older technologies. As for the new "We don't know if they'll confer advantages we haven't seen. And the old fashioned technologies like ours. Ours the same technology used to make the recombinant hepatitis B vaccine that's used all over the world. The nice thing about that is the manufacturing capacity is available at multiple places."He believes there could be eventually more than one vaccine.. One might be better for children, another for the elderly, and another for those with underlying medical conditions. "I think we have to get away from this idea that it's a race and only one person walks away with the prize. It is not going to work that way."
Priority #1 Is A Covid-19 Vaccine
Getty Images
By Barbara SchwarzApr 25, 2020
